medical cannabis
medical cannabis · page 13
- Press releases
Glass Pharms Signs Supply Deal with Mamedica in ‘Milestone for UK Cultivation’
Under the collaboration, Glass Pharms will supply high-quality cannabis flower for use in Mamedica-branded, clinician-prescribed products, reinforcing the value of a fully domestic supply chain for CBPMs (Cannabis-Based Products for Medicinal Use).
- Opinion
‘Europe Risks Legislating Without Execution’: The Entourage Effect CEO on What Europe Needs to Scale
Ahead of the Cannabis Europa 2026, which kicks off next Tuesday (June 24) at the Barbican Centre, we caught up with Eidan Havas, the Founder of one of Australia’s leading medical cannabis product wholesalers, The Entourage Effect.
- Uncategorized
Court Ruling Against German Online Cannabis Clinic Signals Looming Crackdown
Germany tightens control on online cannabis prescriptions. Court ruling bans advertising, while Health Minister calls for stricter access to medical cannabis via online platforms.
- Uncategorized
Cost vs Care: Can Clinics Stay Affordable While Scaling Responsibly?
Medical cannabis clinics are often driven to scale their operations quickly, out of a desire to reach more patients who could benefit from treatment and the need to remain affordable for them. But doing so shouldn’t come at the cost of regulatory compliance.
- Uncategorized
US Spending Bill Takes Aim at Cannabis Rescheduling Project
As more details of the Trump administration’s fiscal plans for the year ahead come to light, so do more thinly veiled attacks on cannabis, this time the ongoing cannabis rescheduling process.
- Medical
Could Australia Be the Next Country to Impose Tariffs on Canadian Cannabis?
Australia’s medical cannabis market is thriving, with revenues expected to grow from around US$600m in 2024 to more than US$1.2bn by 2028, according to Prohibition Partners’ Global Cannabis Report: 5th Edition.
- Uncategorized
Much-Needed Or More Delays? UK Industry Responds to Upcoming ACMD Review of Cannabis-Based Medicines
The UK government has commissioned the Advisory Council on the Misuse of Drugs (ACMD) to carry out a formal review of the current state of play regarding cannabis-based medicinal products.
- Companies
From Farm to Pharma: New Zealand’s Cannabis Powerhouses Are Coming to Europe
With Europe on their radar, a delegation of New Zealand companies is preparing to attend Cannabis Europa later this month. Business of Cannabis caught up with them ahead of the event to explore how they plan to connect with European counterparts, and where they see the most promising opportunities on the horizon.
- Data & Analysis
Germany’s Green Rush: Medical Cannabis Imports Continue Record Growth, As Political Pushback Grows in Tandem
German medical cannabis imports have continued their meteoric rise in the wake of the passage of its Cannabis Act (CanG), rising a further 15% on Q4, 2024 in the first quarter of 2025, totalling 37,223 kg.
- Your #1 Podcast on Cannabis News
Business of Cannabis: Podcast | The Broken Promise of UK Medical Cannabis – Releaf x Fieldfisher
The third in our series of guest episodes features a discussion between the CEO of Releaf, Tim Kirby, and Robert Jappie, a partner at Fieldfisher LLP specialising in regulatory law.
- Uncategorized
What Can the UK Learn From Germany’s Booming Medical Cannabis Market?
With Germany recently making some foundational changes to its medical cannabis framework, helping expand access significantly and driving a surge in patient numbers, we spoke to leading UK-based clinic Releaf to understand what structural, cultural, and clinical lessons the UK can learn from Germany’s success.
- Uncategorized
Denmark Legalises Medical Cannabis Permanently, but ‘Ludicrous’ Subsidy Gap Remains
Denmark has officially passed legislation which will solidify its long-running medical cannabis pilot programme as a permanent fixture of its national healthcare system in what has been described as a ‘victory for patients’.
